NEOGENOMICS INC — Director's Dealing 2021

Jun 5, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2021-06-02

Reporting Person: Kelly Michael Aaron (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-02	Common Stock	A	3081	—	Acquired	4863	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-02	Stock Option (Right to Buy)	$40.9	A	3714	Acquired	2028-06-02	Common Stock (3714.0)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$37.53	2027-05-28	Common Stock (2223.0)	2223	Direct